DR REDDYS LABORATORIES LTD — Investor Relations & Filings
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2024-12-20 | English | |
| Allotment of shares on exercise of Employee Stock Options | 2024-12-20 | English | |
| Issue of letter of confirmation in lieu of share certificates(s) reported lost/ misplaced | 2024-12-10 | English | |
| FORM 6-K | 2024-12-06 | English | |
| Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 | 2024-12-06 | English | |
| 6-K Filing | 2024-12-06 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 11428795 | FORM 6-K | 2024-12-20 | English | ||
| 44652620 | Allotment of shares on exercise of Employee Stock Options | 2024-12-20 | English | ||
| 44652622 | Issue of letter of confirmation in lieu of share certificates(s) reported lost/ misplaced | 2024-12-10 | English | ||
| 11428796 | FORM 6-K | 2024-12-06 | English | ||
| 44652624 | Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 | 2024-12-06 | English | ||
| 28112603 | 6-K Filing | 2024-12-06 | English | ||
| 44652625 | Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 | 2024-12-05 | English | ||
| 11428803 | FORM 6-K | 2024-12-03 | English | ||
| 44652626 | Schedule of Analyst / Institutional Investor Meeting | 2024-12-03 | English | ||
| 11428802 | FORM 6-K | 2024-12-02 | English | ||
| 44652628 | Allotment of shares on exercise of Employee Stock Options | 2024-12-01 | English | ||
| 28112654 | 6-K Filing | 2024-11-29 | English | ||
| 44652630 | Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 | 2024-11-28 | English | ||
| 44652634 | Press Release | 2024-11-28 | English | ||
| 11428799 | FORM 6-K | 2024-11-27 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
DR REDDYS LABORATORIES LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30528/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30528 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30528 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30528 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30528}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DR REDDYS LABORATORIES LTD (id: 30528)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.